Breast Neoplasms: all 12,820 studies

Page 37 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.

• Study of Single Agent Pembrolizumab (MK-3475) Versus Single Agent Chemotherapy for Metastatic Triple Negative Breast Cancer (MK-3475-119/KEYNOTE-119)CompletedNCT02555657Phase 3Results posted
• A Study to Evaluate the Accuracy of a Breast Cancer Locator (BCL) in Patients With Palpable CancersCompletedNCT02550210Not applicableResults posted
• Neoadjuvant Carboplatin and Docetaxel in Triple Negative Breast CancerActive, not recruitingNCT02547987Phase 2Results posted
• A Pre-Surgical PK Study of IM and Intraductally Delivered FulvestrantTerminatedNCT02540330Phase 2Results posted
• Assessment of Diagnostic Accuracy and Performance of Digital Breast Tomosynthesis Compared to MammographyTerminatedNCT02540083Not applicableResults posted
• LY2157299 Monohydrate (LY2157299) and Radiotherapy in Metastatic Breast CancerTerminatedNCT02538471Phase 2Results posted
• MEDI4736 and Tremelimumab in Treating Patients With Metastatic HER2 Negative Breast CancerCompletedNCT02536794Phase 2Results posted
• Palbociclib in Molecularly Characterized ER-positive/HER2-negative Metastatic Breast CancerCompletedNCT02536742Phase 2Results posted
• A Study of Pertuzumab With High-Dose Trastuzumab for the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (MBC) With Central Nervous System (CNS) Progression Post-RadiotherapyCompletedNCT02536339Phase 2Results posted
• Study of F-627 in Women With Breast Cancer Receiving Myelotoxic ChemotherapyCompletedNCT02527746Phase 1Results posted
• Accelerated Partial Breast Radiation Therapy Using High-Dose Rate Brachytherapy in Treating Patients With Early Stage Breast Cancer After SurgeryCompletedNCT02526498Phase 2Results posted
• Implantable Microdevice for In Vivo Drug Sensitivity Testing in Patients With Early Stage, HER2-Positive or Triple Negative Breast CancerCompletedNCT02521363Not applicableResults posted
• Combination of Letrozole, Everolimus and TRC105 in Postmenopausal Women With Hormone-Receptor Positive and Her2 Negative Breast CancerCompletedNCT02520063Phase 1/2Results posted
• Effects of GnRHa on Ovarian Function Against Chemotherapy-induced-gonadotoxicityCompletedNCT02518191Phase 3Results posted
• Study to Evaluate the Efficacy and Safety of Eribulin Mesylate in Combination With Pembrolizumab in Participants With Metastatic Triple-Negative Breast Cancer (mTNBC)CompletedNCT02513472Phase 1/2Results posted
• PALbociclib CoLlaborative Adjuvant StudyActive, not recruitingNCT02513394Phase 3Results posted
• Pilot Mammography Reader Study to Assess Breast Cancer Detection in FFDM Plus DBT Versus FFDM AloneCompletedNCT02511730Not applicableResults posted
• Multicenter Study of Pharmacokinetic-Guided Docetaxel in Breast Cancer Patients Receiving Docetaxel and CyclophosphamideCompletedNCT02502864Phase 4Results posted
• A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid TumorsActive, not recruitingNCT02498613Phase 2Results posted
• Immunotherapy for the Treatment of Breast Cancer Related Upper Extremity Lymphedema (BCRL)CompletedNCT02494206Not applicableResults posted
• Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast CancerCompletedNCT02492711Phase 3Results posted
• Palbociclib in Combination With Fulvestrant or Letrozole in Patients With ER+, HER2- Advanced Breast CancerCompletedNCT02491983Phase 2Results posted
• A Study of Pertuzumab in Participants With Metastatic Breast CancerCompletedNCT02491892Phase 2Results posted
• Neoadjuvant MEDI4736 Concomitant With Weekly Nab-paclitaxel and Dose-dense AC for Stage I-III Triple Negative Breast CancerCompletedNCT02489448Phase 1/2Results posted
• Preoperative Single-Fraction Radiotherapy in Early Stage Breast CancerActive, not recruitingNCT02482376Phase 2Results posted
• Study to Evaluate the Efficacy and Safety of Eribulin Mesylate Administered Biweekly (Q2W) for Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Metastatic Breast CancerCompletedNCT02481050Phase 2Results posted
• Intraoperative Acupoint Stimulation to Prevent Post-Operative Nausea and Vomiting (PONV)CompletedNCT02473042Not applicableResults posted
• Study of Efficacy and Safety of Myl1401O + Taxane vs Herceptin©+ Taxane for 1st Line, Met. Br. Ca.CompletedNCT02472964Phase 3Results posted
• Use of Metformin to Reduce Cardiac Toxicity in Breast CancerTerminatedNCT02472353Phase 2Results posted
• Efficacy and Safety of GTx-024 in Patients With Estrogen Receptor (ER)+/Androgen Receptor (AR)+ Breast CancerCompletedNCT02463032Phase 2Results posted
• Taselisib and Enzalutamide in Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast CancerTerminatedNCT02457910Phase 1/2Results posted
• Liposomal Doxorubicin, Bevacizumab, and Everolimus in Patients With Locally Advanced TNBC With Tumors Predicted Insensitive to Standard Chemotherapy; A Moonshot InitiativeCompletedNCT02456857Phase 2Results posted
• Assessment of Functional Status of Estrogen Receptors in Breast Cancer by Positron Emission TomographyCompletedNCT02455453Phase 2Results posted
• A Study of Accelerated 3 Fraction Photon,Proton or Brachytherapy for Early Invasive and Noninvasive Breast CaCompletedNCT02453737Phase 2Results posted
• A Study of Palbociclib in Combination With Bazedoxifene in Hormone Receptor Positive Breast CancerCompletedNCT02448771Phase 1/2Results posted
• A Single Arm, Tolerability and Safety Phase IV Study of Fulvestrant(Faslodex® ) as 2nd Line and Later Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast CancerCompletedNCT02447328Phase 4Results posted
• Study of Pembrolizumab (MK-3475) Monotherapy for Metastatic Triple-Negative Breast Cancer (MK-3475-086/KEYNOTE-086)CompletedNCT02447003Phase 2Results posted
• Safety Study of Pertuzumab (in Combination With Trastuzumab and Docetaxel) in Indian Participants With Breast CancerCompletedNCT02445586Phase 4Results posted
• Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant ChemotherapyActive, not recruitingNCT02445391Phase 3Results posted
• A Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast CancerCompletedNCT02441946Phase 2Results posted
• Feasibility Study of Intraoperative Imaging in Breast CancerCompletedNCT02438358Phase 1/2Results posted
• Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant in Men and Postmenopausal Women With Advanced Breast Cancer Which Progressed on or After Aromatase Inhibitor Treatment.CompletedNCT02437318Phase 3Results posted
• Efficacy Study of MCS110 Given With Carboplatin and Gemcitabine in Advanced Triple Negative Breast Cancer (TNBC)CompletedNCT02435680Phase 2Results posted
• European Celecoxib Trial in Primary Breast CancerCompletedNCT02429427Phase 3Results posted
• A Study of Atezolizumab in Combination With Nab-Paclitaxel Compared With Placebo With Nab-Paclitaxel for Participants With Previously Untreated Metastatic Triple-Negative Breast Cancer (IMpassion130)CompletedNCT02425891Phase 3Results posted
• A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Breast CancerTerminatedNCT02423902Phase 1/2Results posted
• Study of Efficacy and Safety of LEE011 in Men and Postmenopausal Women With Advanced Breast Cancer.CompletedNCT02422615Phase 3Results posted
• Comparison of Use of Indocyanine Green and 99mTc-labeled Radiotracer for Axillary Lymphatic Mapping in Patients With Breast CancerCompletedNCT02419807Not applicableResults posted
• Safety and Efficacy of Trastuzumab as Part of Breast Cancer Treatment RegimenCompletedNCT02419742Phase 4Results posted
• Typhoid Vaccine in Testing Response to Immune Stress in Patients With Stage I-IIIA Breast CancerCompletedNCT02415387Early Phase 1Results posted
• Neoadjuvant Study of Two Platinum Regimens in Triple Negative Breast CancerCompletedNCT02413320Phase 2Results posted
• A Multi-Center Study of Ibrutinib in Combination With MEDI4736 in Subjects With Relapsed or Refractory Solid TumorsCompletedNCT02403271Phase 1/2Results posted
• Phase 2 Trial of Selinexor (KPT-330) for Metastatic Triple Negative Breast Cancer (TNBC)CompletedNCT02402764Phase 2Results posted
• Phase II Trial of Talazoparib in BRCA1/2 Wild-type HER2-negative Breast Cancer and Other Solid TumorsCompletedNCT02401347Phase 2Results posted
• An Open-Label Study to Characterize the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and LoperamideCompletedNCT02400476Phase 2Results posted
• Reversing Therapy Resistance With Epigenetic-Immune ModificationTerminatedNCT02395627Phase 2Results posted
• Nintedanib For HER2-Negative Metastatic Inflammatory Breast Cancer (MIBC)TerminatedNCT02389764Phase 2Results posted
• Intraoperative Radiotherapy After Local Recurrence in Breast CancerCompletedNCT02386371Not applicableResults posted
• A Study of Palbociclib in Combination With Fulvestrant or Tamoxifen as Treatment for Metastatic Breast CancerCompletedNCT02384239Phase 2Results posted
• Fasting on Newly Diagnosed Breast CancerTerminatedNCT02379585Phase 1/2Results posted
• BYL719 and Nab-Paclitaxel in Locally Recurrent or Metastatic HER-2 Negative Breast CancerCompletedNCT02379247Phase 1/2Results posted
• Study to Assess the Efficacy and Safety of the Epigenetic Modifying Effects of CC-486 (Oral Azacitidine) in Combination With FulvestrantTerminatedNCT02374099Phase 2Results posted
• A Double-blind Study of Paclitaxel in Combination With Reparixin or Placebo for Metastatic Triple-Negative Breast CancerCompletedNCT02370238Phase 2Results posted
• Efficacy and Safety of GTx-024 in Patients With Androgen Receptor-Positive Triple Negative Breast Cancer (AR+ TNBC)TerminatedNCT02368691Phase 2Results posted
• Trial of Ra-223 Dichloride in Combination With Hormonal Therapy and Denosumab in the Treatment of Patients With Hormone-Positive Bone-Dominant Metastatic Breast CancerCompletedNCT02366130Phase 2Results posted
• CyberKnife Stereotactic Accelerated Partial Breast Irradiation (SAPBI)TerminatedNCT02365714Phase 1/2Results posted
• Testing Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves SurvivalCompletedNCT02364557Phase 2/3Results posted
• Metformin for Reduction of Paclitaxel-Related Neuropathy in Patients With Breast CancerTerminatedNCT02360059Phase 2Results posted
• Omega-3 Fatty Acid in Reducing Cancer-Related Fatigue in Breast Cancer SurvivorsCompletedNCT02352779Not applicableResults posted
• Evaluate Cardiac Function Using Cardiac MRI and Dosimetric CorrelationCompletedNCT02348684Results posted
• Neoadjuvant Hormonal Therapy Combined With ChemoimmunotherapyTerminatedNCT02345772Phase 1/2Results posted
• A Study of Taselisib + Fulvestrant Versus Placebo + Fulvestrant in Participants With Advanced or Metastatic Breast Cancer Who Have Disease Recurrence or Progression During or After Aromatase Inhibitor TherapyTerminatedNCT02340221Phase 3Results posted
• SentiMag® Intraoperative Comparison in Breast CancerCompletedNCT02336737Not applicableResults posted
• T-DM1+Pertuzumab in Pre-OP Early-Stage HER2+ BRCAActive, not recruitingNCT02326974Phase 2Results posted
• Assessment of Diagnostic Accuracy and Performance of Digital Breast Tomosynthesis Compared to Mammography (ADAPT)TerminatedNCT02324205Not applicableResults posted
• A Study of Cobimetinib Plus Paclitaxel, Cobimetinib Plus Atezolizumab Plus Paclitaxel, or Cobimetinib Plus Atezolizumab Plus Nab-Paclitaxel as Initial Treatment for Participants With Triple-Negative Breast Cancer That Has SpreadTerminatedNCT02322814Phase 2Results posted
• Feasibility of Ultrasound Microbubble Contrast-Enhanced (CEUS) Sentinel Lymph Node Imaging With Guided Biopsy in Breast Cancer PatientsCompletedNCT02321527Not applicableResults posted
• End-of-Life Care for African AmericansCompletedNCT02320123Not applicableResults posted
• Pegylated Liposomal Doxorubicin Hydrochloride and Carboplatin Followed by Surgery and Paclitaxel in Treating Patients With Triple Negative Stage II-III Breast CancerActive, not recruitingNCT02315196Phase 2Results posted
• Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing MastectomyCompletedNCT02314156Phase 2Results posted
• Phase 2 Etirinotecan Pegol in Refractory Brain Metastases & Advanced Lung Cancer / Metastatic Breast CancerCompletedNCT02312622Phase 2Results posted
• Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast CancerActive, not recruitingNCT02311933Phase 2Results posted
• Trial of Active Immunotherapy With OBI-833 (Globo H-CRM197) in Advanced/Metastatic Gastric, Lung, Colorectal or Breast Cancer SubjectsCompletedNCT02310464Phase 1Results posted
• A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer, Non-small Cell Lung Cancer, or Melanoma That Has Spread to the BrainCompletedNCT02308020Phase 2Results posted
• Assessment of Diagnostic Accuracy and Performance of Digital Breast Tomosynthesis Compared to MammographyCompletedNCT02306265Not applicableResults posted
• A Study of Ipatasertib (GDC-0068) in Combination With Paclitaxel as Neoadjuvant Treatment for Participants With Early Stage Triple Negative Breast CancerCompletedNCT02301988Phase 2Results posted
• A Study Evaluating PF-03084014 In Patients With Advanced Breast Cancer With Or Without Notch AlterationsTerminatedNCT02299635Phase 2Results posted
• Phase II Trial of Combination Immunotherapy With NeuVax and Trastuzumab in High-risk HER2+ Breast Cancer PatientsCompletedNCT02297698Phase 2Results posted
• A Study Of Palbociclib (PD-0332991) + Letrozole VS. Placebo+ Letrozole For 1st Line Treatment Of Asian Postmenopausal Women With ER+/HER2- Advanced Breast Cancer [PALOMA-4]CompletedNCT02297438Phase 3Results posted
• Minocycline Hydrochloride in Reducing Chemotherapy-Induced Peripheral Neuropathy and Acute Pain in Patients With Breast Cancer Undergoing Treatment With PaclitaxelCompletedNCT02297412Phase 2Results posted
• Locally Advanced Breast Cancer: Individualized Treatment Based On Tumor Molecular CharacteristicsTerminatedNCT02297230Phase 1/2Results posted
• A Phase II Randomized Study Evaluating the Biological and Clinical Effects of the Combination of Palbociclib With Letrozole as Neoadjuvant Therapy in Post-Menopausal Women With Estrogen-Receptor Positive Primary Breast CancerCompletedNCT02296801Phase 2Results posted
• Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive CancerActive, not recruitingNCT02293954Not applicableResults posted
• Everolimus Combined With Anti-estrogen Therapy in Hormone-Receptor-Positive HER-2 Negative Advanced Breast CancerCompletedNCT02291913Phase 2Results posted
• Sentinel Lymph Node Biopsy Findings in Patients With Breast CancerCompletedNCT02287675Phase 4Results posted
• Can HER2 Targeted PET/CT Imaging Identify Unsuspected HER2 Positive Breast Cancer Metastases, Which Are Amenable to HER2 Targeted Therapy?CompletedNCT02286843Not applicableResults posted
• Evaluation of Cryoprotection Induced Nail Toxicity Docetaxel Low Cumulative DoseCompletedNCT02283983Not applicableResults posted
• Talazoparib Before Standard Therapy in Treating Patients With Invasive, BRCA-Mutated Breast CancerCompletedNCT02282345Phase 2Results posted
• Study of Concurrent Paclitaxel and Radiation: Correlation of Tumor Profiles With Pathologic ResponseCompletedNCT02280252Phase 2Results posted
• Study Assessing The Interest of Indocyanine Green Fluorescence Imaging With Radioisotope Method For Sentinel Lymph Node Biopsy in Patients With Breast CancerCompletedNCT02279108Phase 3Results posted

← Breast Neoplasms overview